These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 29288746
21. Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawal. Sun L, Hu L, Li Y, Cui C. Brain Struct Funct; 2014 Sep; 219(5):1755-71. PubMed ID: 23775491 [Abstract] [Full Text] [Related]
22. Role of dopamine D1-like receptor within the nucleus accumbens in acute food deprivation- and drug priming-induced reinstatement of morphine seeking in rats. Sadeghzadeh F, Babapour V, Haghparast A. Behav Brain Res; 2015 Sep; 287():172-81. PubMed ID: 25835321 [Abstract] [Full Text] [Related]
23. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation. Oh JH, Hwang JY, Hong SI, Ma SX, Seo JY, Lee SY, Kim HC, Jang CG. Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823 [Abstract] [Full Text] [Related]
26. Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens. Hong SI, Kim MJ, You IJ, Kwon SH, Ma SX, Hwang JY, Seo JY, Ko YH, Lee BR, Lee SY, Jang CG. Psychopharmacology (Berl); 2016 Apr; 233(8):1405-13. PubMed ID: 26887589 [Abstract] [Full Text] [Related]
29. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Corvol JC, Valjent E, Pascoli V, Robin A, Stipanovich A, Luedtke RR, Belluscio L, Girault JA, Hervé D. Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155 [Abstract] [Full Text] [Related]
30. The Role of Dopaminergic Signaling in the Medial Prefrontal Cortex for the Expression of Cocaine-Induced Conditioned Place Preference in Rats. Shinohara F, Kamii H, Minami M, Kaneda K. Biol Pharm Bull; 2017 May; 40(11):1983-1989. PubMed ID: 29093348 [Abstract] [Full Text] [Related]
31. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core. Kobrin KL, Arena DT, Heinrichs SC, Nguyen OH, Kaplan GB. Behav Brain Res; 2017 Mar 30; 322(Pt A):18-28. PubMed ID: 28089852 [Abstract] [Full Text] [Related]
36. 1-Phenylcyclohexan-1-amine hydrochloride (PCA HCl) alters mesolimbic dopamine system accompanied by neuroplastic changes: A neuropsychopharmacological evaluation in rodents. Abiero A, Perez Custodio RJ, Botanas CJ, Ortiz DM, Sayson LV, Kim M, Lee HJ, Yoon S, Lee YS, Cheong JH, Kim HJ. Neurochem Int; 2021 Mar 30; 144():104962. PubMed ID: 33460722 [Abstract] [Full Text] [Related]
37. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. Meririnne E, Kankaanpää A, Seppälä T. J Pharmacol Exp Ther; 2001 Aug 30; 298(2):539-50. PubMed ID: 11454915 [Abstract] [Full Text] [Related]
38. Long-term compulsive exercise reduces the rewarding efficacy of 3,4-methylenedioxymethamphetamine. Chen HI, Kuo YM, Liao CH, Jen CJ, Huang AM, Cherng CG, Su SW, Yu L. Behav Brain Res; 2008 Feb 11; 187(1):185-9. PubMed ID: 17949827 [Abstract] [Full Text] [Related]
39. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm. Bailey A, Metaxas A, Yoo JH, McGee T, Kitchen I. Eur J Neurosci; 2008 Aug 11; 28(4):759-70. PubMed ID: 18671743 [Abstract] [Full Text] [Related]